Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Focal cortical dysplasia IIIa (FCD IIIa) is a common histopathological finding in temporal lobe epilepsy. However, subtle alterations in the temporal neocortex of FCD IIIa renders presurgical diagnosis and definition of the resective range challenging.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To explore neuroimaging phenotyping and structural‐metabolic‐electrophysiological alterations in FCD IIIa.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Subjects</h3><p>One hundred and sixty‐seven subjects aged 4–39 years, including 64 FCD IIIa patients, 89 healthy controls and 14 FCD I patients as disease controls.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>3 T, fast‐spin‐echo T<sub>2</sub>‐weighted fluid‐attenuated inversion recovery (FLAIR), synthetic T<sub>1</sub>‐weighted magnetization prepared rapid acquisition gradient echo (MPRAGE). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Surface‐based linear model was applied to reveal neuroimaging phenotyping in FCD IIIa and assess its relationship with clinical variables. Logistic regression was implemented to identify FCD IIIa patients. Epileptogenicity mapping (EM) was conducted to explore the structural‐metabolic‐electrophysiological alterations in temporal neocortex of FCD IIIa.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Student's <i>t</i>‐test was applied to determine the significance of paired differences. Calibration curves were plotted to assess the goodness‐of‐fit (GOF) of the models, combined with the Hosmer‐Lemeshow test. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>FCD IIIa exhibited widespread hyperintensities in temporal neocortex, and these alterations correlated with disease duration (<i>P</i><sub>uncorrected</sub> < 0.01). Machine learning model accurately identified 84.4% of FCD IIIa patients, 92.1% of healthy controls and 92.9% of FCD I patients. Cross‐modality analysis showed a significant negative correlation between FLAIR hyperintensity and positron emission tomography hypometabolism <i>P</i> < 0.01). Furthermore, epileptogenic cortices were located predominantly in brain regions with FLAIR hyperintensity and hypometabolism. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>FCD IIIa exhibited widespread temporal neocortex FLAIR hyperintensity. Automated machine learning of neuroimaging patterns is conducive for accurate identification of FCD IIIa. The degree and distribution of morphological alterations related to the extent of metabolic and epileptogenic abnormalities, lending support to its potential value for reduction of the radiative and invasive approaches during presurgical workup.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2</p></section>

Mechanistic Analysis of Micro-Neurocircuits Underlying the Epileptogenic Zone in Focal Cortical Dysplasia Patients

Excitatory and Inhibitory Synaptic Connectivity to Layer V Fast-Spiking Interneurons in the Freeze Lesion Model of Cortical Microgyria

Pathological Networks Involving Dysmorphic Neurons in Type II Focal Cortical Dysplasia

Identification and verification of key molecules in the epileptogenic process of focal cortical dysplasia

Morphological Analysis of Brain MRI and Its Application in Focal Cortical Dysplasia

Excitatory neurons and oligodendrocyte precursor cells are vulnerable to focal cortical dysplasia type IIIa as suggested by single‐nucleus multiomics

Pathogenesis and Therapeutic Targets of Focal Cortical Dysplasia Based on Bioinformatics Analysis

Brain Functional Connectivity Patterns in Focal Cortical Dysplasia Related Epilepsy

Altered Expression of Neuropeptide Y Receptors Caused by Focal Cortical Dysplasia in Human Intractable Epilepsy

Pathophysiological mechanisms underlying the development of focal cortical dysplasia and their association with epilepsy: Experimental models as a research approach

Identification of pericyte loss and neutrophils infiltration in Focal cortical dysplasia by Integrated Analysis of Single-Cell and Bulk RNA-Sequencing

Multimodal mapping of regional brain vulnerability to focal cortical dysplasia

Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients

Prominent contributions of selective neuronal subtypes to pediatric drug-resistant focal dysplasia

Spatial transcriptomics in focal cortical dysplasia type IIb

Automated Detection of Focal Cortical Dysplasia Type II with Surface-Based Magnetic Resonance Imaging Postprocessing and Machine Learning

Neuroimaging gradient alterations and epileptogenic prediction in focal cortical dysplasia IIIa

[The Screening of Potential Biological Markers of Seizure Onset Zone in Focal Cortical Dysplasia Based on Bioinformatics Analysis].

Neuroimaging Phenotyping and Assessment of Structural‐Metabolic‐Electrophysiological Alterations in the Temporal Neocortex of Focal Cortical Dysplasia IIIa

A Study on the Correlation Between Electroencephalography Characteristic and Histopathological Change in Epilepsy Patients Due to Focal Cortical Dysplasia

Diagnostic methods and treatment options for focal cortical dysplasia